Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ponatinib-Related Vasospastic Angina.
Shindo M, Komiyama C, Yamaguchi T, Kageyama K, Yamamoto H, Fujimoto Y, Uchida N, Kodama T. Shindo M, et al. Among authors: uchida n. Int Heart J. 2024;65(2):349-353. doi: 10.1536/ihj.23-355. Int Heart J. 2024. PMID: 38556342 Free article.
Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.
Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K. Kondo T, et al. Among authors: uchida n. Am J Hematol. 2017 Sep;92(9):902-908. doi: 10.1002/ajh.24793. Epub 2017 Jun 9. Am J Hematol. 2017. PMID: 28543934 Free article. Clinical Trial.
Cryptococcal meningitis following umbilical cord blood transplantation, association between the occurrence of cryptococcal infection and tacrolimus discontinuation among allogeneic hematopoietic stem cell recipients.
Mitsuki T, Kimura M, Araoka H, Kageyama K, Takagi S, Yamamoto G, Nakamura S, Miyazaki Y, Uchida N, Yoneyama A, Taniguchi S. Mitsuki T, et al. Among authors: uchida n. J Infect Chemother. 2019 Apr;25(4):289-292. doi: 10.1016/j.jiac.2018.09.006. Epub 2018 Oct 10. J Infect Chemother. 2019. PMID: 30316744
No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation.
Wada S, Asano-Mori Y, Yamamoto H, Yuasa M, Kageyama K, Kaji D, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Yoneyama A, Makino S, Taniguchi S. Wada S, et al. Among authors: uchida n. Bone Marrow Transplant. 2019 May;54(5):765-768. doi: 10.1038/s41409-018-0375-2. Epub 2018 Nov 6. Bone Marrow Transplant. 2019. PMID: 30401968 Clinical Trial. No abstract available.
Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Akahoshi Y, Nishiwaki S, Mizuta S, Ohashi K, Uchida N, Tanaka M, Fukuda T, Ozawa Y, Takahashi S, Onizuka M, Shiratori S, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Kako S; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Akahoshi Y, et al. Among authors: uchida n. Cancer Sci. 2019 Oct;110(10):3255-3266. doi: 10.1111/cas.14167. Epub 2019 Aug 29. Cancer Sci. 2019. PMID: 31402561 Free PMC article.
Splenomegaly Negatively Impacts Neutrophil Engraftment in Cord Blood Transplantation.
Yuasa M, Yamamoto H, Kageyama K, Kaji D, Taya Y, Takagi S, Yamamoto G, Asano-Mori Y, Wake A, Yoneyama A, Makino S, Uchida N, Taniguchi S. Yuasa M, et al. Among authors: uchida n. Biol Blood Marrow Transplant. 2020 Sep;26(9):1689-1696. doi: 10.1016/j.bbmt.2020.05.018. Epub 2020 Jun 4. Biol Blood Marrow Transplant. 2020. PMID: 32505808 Free article.
HHV-6 associated diseases are one of the major factors on higher early CNS complications in CB recipients than in those of BM/PBSC.
Kageyama K, Uchida N, Yamamoto H, Takagi S, Ebihara M, Yuasa M, Kaji D, Nishida A, Ishiwata K, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. Kageyama K, et al. Among authors: uchida n. Bone Marrow Transplant. 2021 Mar;56(3):686-688. doi: 10.1038/s41409-020-01028-5. Epub 2020 Aug 11. Bone Marrow Transplant. 2021. PMID: 32782352 No abstract available.
Prognostic Impact of Cytogenetic Evolution on the Outcome of Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Nonremission: A Single-Institute Analysis of 212 Recipients.
Yuasa M, Yamamoto H, Mitsuki T, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Wake A, Koike Y, Makino S, Uchida N, Taniguchi S. Yuasa M, et al. Among authors: uchida n. Biol Blood Marrow Transplant. 2020 Dec;26(12):2262-2270. doi: 10.1016/j.bbmt.2020.08.026. Epub 2020 Aug 29. Biol Blood Marrow Transplant. 2020. PMID: 32871257 Free article.
Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Ogura S, Kimura M, Takagi S, Mitsuki T, Yuasa M, Kageyama K, Kaji D, Nishida A, Taya Y, Ishiwata K, Yamamoto H, Asano-Mori Y, Yamamoto G, Uchida N, Wake A, Taniguchi S, Araoka H. Ogura S, et al. Among authors: uchida n. Eur J Clin Microbiol Infect Dis. 2021 May;40(5):941-948. doi: 10.1007/s10096-020-04096-z. Epub 2020 Nov 13. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33185742
Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Akahoshi Y, Arai Y, Nishiwaki S, Mizuta S, Marumo A, Uchida N, Kanda Y, Sakai H, Takada S, Fukuda T, Fujisawa S, Ashida T, Tanaka J, Atsuta Y, Kako S. Akahoshi Y, et al. Among authors: uchida n. Int J Hematol. 2021 Jun;113(6):832-839. doi: 10.1007/s12185-021-03094-x. Epub 2021 Feb 11. Int J Hematol. 2021. PMID: 33570732 Clinical Trial.
1,412 results